Approximately 50% of women experience at least one bone fracture postmenopause.
Current screening approaches target anti-fracture interventions to women aged> 60 years …

Objective To update the evidence-based position statement published by The North
American Menopause Society (NAMS) in 2002 regarding the management of osteoporosis …

Osteoporosis increases the risk of fractures, which are associated with increased mortality
and lower quality of life. Patients with prevalent fracture are at high risk to of sustaining …

In the past few years, several drugs have become available that can reduce substantially the
incidence of fractures in postmenopausal women with osteoporosis. These large clinical …

* Corresponding author. Department of Clinical Epidemiology and Biostatistics, McMaster
University, 1200 Main Street West, Room 2C12, Hamilton, Ontario, Canada L8N 3Z5. E-mail …

Although many agents have been used in the treatment of osteoporosis, only in the past 10
years have large, double-blind placebo-controlled trials been published on postmenopausal …

Antiresorptive treatments for postmenopausal osteoporosis have been studied extensively,
but due to the volume of published data and lack of head-to-head trials, it is difficult to …

Studies examining real-world effectiveness of osteoporosis therapies are beset by
limitations due to confounding by indication. By evaluating longitudinal changes in fracture …

Postmenopausal osteoporosis : Current Opinion in Endocrinology, Diabetes and Obesity
Postmenopausal osteoporosis : Current Opinion in Endocrinology, Diabetes and Obesity Log …

Background: Although osteoporotic fractures present an enormous health burden, it is not
clear whether screening to identify high-risk persons is appropriate. Purpose: To examine …